Monoclonal Antibody Biologics and Biosimilars - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2757524
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 141
-
According to Ample Market Research, the global market for Monoclonal Antibody Biologics and Biosimilars should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Monoclonal Antibody Biologics and Biosimilars market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Monoclonal Antibody Biologics and Biosimilars market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Cancer grew percent to account for percent of the total market sales, and Autoimmune Disease grew percent.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report studies and analyses global Monoclonal Antibody Biologics and Biosimilars status and future trends, to help determine the Monoclonal Antibody Biologics and Biosimilars market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Monoclonal Antibody Biologics and Biosimilars, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Monoclonal Antibody Biologics and Biosimilars market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Monoclonal Antibody Biologics and Biosimilars by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Monoclonal Antibody Biologics and Biosimilars by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Monoclonal Antibody Biologics and Biosimilars key consuming regions, consumption value and demand structure
(5) Monoclonal Antibody Biologics and Biosimilars industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Innovent Biologics
Market segment by Type, covers
Biologics
Biosimilars
Market segment by Application, can be divided into
Cancer
Autoimmune Disease
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Monoclonal Antibody Biologics and Biosimilars product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Monoclonal Antibody Biologics and Biosimilars market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Monoclonal Antibody Biologics and Biosimilars market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Monoclonal Antibody Biologics and Biosimilars industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Monoclonal Antibody Biologics and Biosimilars Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Monoclonal Antibody Biologics and Biosimilars Definition
1.2 Global Monoclonal Antibody Biologics and Biosimilars Market Size and Forecast
1.3 China Monoclonal Antibody Biologics and Biosimilars Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Monoclonal Antibody Biologics and Biosimilars Market Size: China VS Global Growth Rate, 2018-2029
1.6 Monoclonal Antibody Biologics and Biosimilars Market Dynamics
1.6.1 Monoclonal Antibody Biologics and Biosimilars Market Drivers
1.6.2 Monoclonal Antibody Biologics and Biosimilars Market Restraints
1.6.3 Monoclonal Antibody Biologics and Biosimilars Industry Trends
1.6.4 Monoclonal Antibody Biologics and Biosimilars Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Monoclonal Antibody Biologics and Biosimilars, Global Market Share by Company, 2018-2023
2.2 Global Monoclonal Antibody Biologics and Biosimilars Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Monoclonal Antibody Biologics and Biosimilars Concentration Ratio
2.4 Global Monoclonal Antibody Biologics and Biosimilars Mergers & Acquisitions, Expansion Plans
2.5 Global Monoclonal Antibody Biologics and Biosimilars Major Companies Product Type
2.6 Head Office and Monoclonal Antibody Biologics and Biosimilars Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Monoclonal Antibody Biologics and Biosimilars, China Market Share by Company, 2018-2023
3.2 China Monoclonal Antibody Biologics and Biosimilars Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Monoclonal Antibody Biologics and Biosimilars Industry Chain
4.2 Monoclonal Antibody Biologics and Biosimilars Upstream Analysis
4.2.1 Monoclonal Antibody Biologics and Biosimilars Core Raw Materials
4.2.2 Main Manufacturers of Monoclonal Antibody Biologics and Biosimilars Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Monoclonal Antibody Biologics and Biosimilars Production Mode
4.6 Monoclonal Antibody Biologics and Biosimilars Procurement Model
4.7 Monoclonal Antibody Biologics and Biosimilars Industry Sales Model and Sales Channels
4.7.1 Monoclonal Antibody Biologics and Biosimilars Sales Model
4.7.2 Monoclonal Antibody Biologics and Biosimilars Typical Distributors
5 Sights by Type5.1 Monoclonal Antibody Biologics and Biosimilars Classification
5.1.1 Biologics
5.1.2 Biosimilars5.2 By Type, Global Monoclonal Antibody Biologics and Biosimilars Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Monoclonal Antibody Biologics and Biosimilars Consumption Value, 2018-2029
6 Sights by Application6.1 Monoclonal Antibody Biologics and Biosimilars Segment by Application
6.1.1 Cancer
6.1.2 Autoimmune Disease
6.1.3 Other6.2 By Application, Global Monoclonal Antibody Biologics and Biosimilars Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Monoclonal Antibody Biologics and Biosimilars Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Monoclonal Antibody Biologics and Biosimilars Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Monoclonal Antibody Biologics and Biosimilars Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Monoclonal Antibody Biologics and Biosimilars & Forecasts, 2018-2029
7.3.2 By Country, North America Monoclonal Antibody Biologics and Biosimilars Market Size Market Share7.4 Europe
7.4.1 Europe Monoclonal Antibody Biologics and Biosimilars Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Monoclonal Antibody Biologics and Biosimilars Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Monoclonal Antibody Biologics and Biosimilars Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Monoclonal Antibody Biologics and Biosimilars Market Size Market Share7.6 South America
7.6.1 South America Monoclonal Antibody Biologics and Biosimilars Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Monoclonal Antibody Biologics and Biosimilars Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Monoclonal Antibody Biologics and Biosimilars Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Monoclonal Antibody Biologics and Biosimilars Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029
8.3.2 By Type, U.S. Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029
8.4.2 By Type, Europe Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029
8.5.2 By Type, China Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029
8.6.2 By Type, Japan Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029
8.7.2 By Type, South Korea Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029
8.9.2 By Type, India Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Monoclonal Antibody Biologics and Biosimilars Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Roche
9.1.1 Roche Company Information, Head Office, Market Area and Industry Position
9.1.2 Roche Company Profile and Main Business
9.1.3 Roche Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.1.4 Roche Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.1.5 Roche Recent Developments9.2 Amgen
9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.2.2 Amgen Company Profile and Main Business
9.2.3 Amgen Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.2.4 Amgen Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.2.5 Amgen Recent Developments9.3 AbbVie
9.3.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.3.2 AbbVie Company Profile and Main Business
9.3.3 AbbVie Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.3.4 AbbVie Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.3.5 AbbVie Recent Developments9.4 Sanofi
9.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.4.2 Sanofi Company Profile and Main Business
9.4.3 Sanofi Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.4.4 Sanofi Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.4.5 Sanofi Recent Developments9.5 Johnson & Johnson
9.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.5.2 Johnson & Johnson Company Profile and Main Business
9.5.3 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.5.4 Johnson & Johnson Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.5.5 Johnson & Johnson Recent Developments9.6 Pfizer
9.6.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.6.2 Pfizer Company Profile and Main Business
9.6.3 Pfizer Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.6.4 Pfizer Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.6.5 Pfizer Recent Developments
9.7 Eli Lilly
9.7.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
9.7.2 Eli Lilly Company Profile and Main Business
9.7.3 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.7.4 Eli Lilly Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.7.5 Eli Lilly Recent Developments
9.8 Novartis
9.8.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.8.2 Novartis Company Profile and Main Business
9.8.3 Novartis Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.8.4 Novartis Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.8.5 Novartis Recent Developments
9.9 Merck
9.9.1 Merck Company Information, Head Office, Market Area and Industry Position
9.9.2 Merck Company Profile and Main Business
9.9.3 Merck Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.9.4 Merck Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.9.5 Merck Recent Developments9.10 Biogen
9.10.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.10.2 Biogen Company Profile and Main Business
9.10.3 Biogen Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.10.4 Biogen Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.10.5 Biogen Recent Developments
9.11 Celltrion
9.11.1 Celltrion Company Information, Head Office, Market Area and Industry Position
9.11.2 Celltrion Company Profile and Main Business
9.11.3 Celltrion Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.11.4 Celltrion Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.11.5 Celltrion Recent Developments
9.12 Sobi
9.12.1 Sobi Company Information, Head Office, Market Area and Industry Position
9.12.2 Sobi Company Profile and Main Business
9.12.3 Sobi Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.12.4 Sobi Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.12.5 Sobi Recent Developments
9.13 3SBIO
9.13.1 3SBIO Company Information, Head Office, Market Area and Industry Position
9.13.2 3SBIO Company Profile and Main Business
9.13.3 3SBIO Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.13.4 3SBIO Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.13.5 3SBIO Recent Developments
9.14 Innovent Biologics
9.14.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position
9.14.2 Innovent Biologics Company Profile and Main Business
9.14.3 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Models, Specifications and Application
9.14.4 Innovent Biologics Monoclonal Antibody Biologics and Biosimilars Revenue and Gross Margin, 2018-2023
9.14.5 Innovent Biologics Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Monoclonal Antibody Biologics and Biosimilars Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Monoclonal Antibody Biologics and Biosimilars Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Monoclonal Antibody Biologics and Biosimilars Global and China Top Players has a wide range of applications, including
The Monoclonal Antibody Biologics and Biosimilars Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Monoclonal Antibody Biologics and Biosimilars Global and China Top Players Market across the extensive corporate landscape.
The Monoclonal Antibody Biologics and Biosimilars Global and China Top Players Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.
